Contribute to the health of all mankin
Gathering life energy and Caring for human health
The spirit of pursuing the sun and achieving dreams
Health, prosperity and happiness
Industrial layout
Contrast agent series
Over the past 20 years, the company has maintained a good and stable development momentum and has become the leading enterprise of X-CT nonionic contrast agent bulk drugs in China. The products that have the industrialization capability include iohexol bulk drug, iopamidol bulk drug, iodophor bulk drug, iopromide bulk drug, iodixanol bulk drug, etc.
Fluoroquinolones series
In terms of quinolone series bulk drug, the company is at the domestic leading level in the separation and synthesis of impurities in levofloxacin series products, ranking fourth in the country in production scale, and is one of the largest levofloxacin series manufacturers in China.
Starry Pharmaceutical
Deeming "gathering life energy and caring for human health" as its business philosophy and "replacing imports with specialized products and filling domestic gaps" as its development policy, the company has continuously enriched X-ray contrast agent series products and strived to maximize the scale of existing core products of X-ray contrast agent bulk drugs. At the same time, it is committed to developing new drugs with independent intellectual property rights and accelerating its development into the field of preparations. The company will strive to become a well-known pharmaceutical enterprise in China and even in the world while building Starry into an outstanding pharmaceutical brand.
-
1997
YearEstablishment time
-
603520
Securities code
-
2000
IndividualExcellent staff
News
2022
07 12
2022
06 24
2022
06 02
2022
02 10
You may need
Have questions about us? We are ready to help you.
Products
News
Responsibility
Wap
官方公众号
官方手机站
Copyright © 2019 Zhejiang Starry Pharmaceutical Co., Ltd. All Rights Reserved. 浙ICP备18046522号 Power：300.cn